In Asia Pacific, specifically in China, Japan, and South Korea, the vitiligo treatment market is also anticipated to witness substantial growth. The rising awareness about skin disorders, increasing healthcare expenditure, and the availability of advanced treatment options are key factors driving market growth in these countries.
In Europe, including the United Kingdom, Germany, and France, the vitiligo treatment market is projected to witness steady growth. The increasing prevalence of vitiligo, coupled with favorable healthcare policies and the presence of key market players, is expected to drive market growth in this region.